Figure 5From: Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2 GC7 pre-treatment prevents A549 cells from undergoing EMT after TGF-β1 stimulation. (A) morphology (B) Western blotting (C) immunofluorescence (D) wound-healing assay (E) Transwell-Matrigel invasion assay.Back to article page